Shopping Cart (0)
My Account

 Shopping Cart
Conferences | Training Courses | Market Reports | Managed Events | Past Conferences | Update Me
SELECTBIO Conferences Next Generation Sequencing Asia 2016: Clinical Applications
Conferences  \  Next Generation Sequencing Asia 2016: Clinical Applications  \  Agenda  \  Kevin Wang
RegisterLogin

Kevin Wang's Biography


Kevin Wang, General Manager, Oncology department, Berry Genomics Corp.

Over 20 years sequencing experience. Worked at Applied Biosystems, Life Technologies, Thermo
Fisher, and ACT Genomics. Over 5 years oncology diagnostics experience.

Kevin Wang Image

Real World Data of ctDNA Assay with cSMART Technology for NSCLC in China

Thursday, 1 December 2016 at 14:30

Add to Calendar ▼2016-12-01 14:30:002016-12-01 15:30:00Europe/LondonReal World Data of ctDNA Assay with cSMART Technology for NSCLC in ChinaNext Generation Sequencing Asia 2016: Clinical Applications in Taipei, TaiwanTaipei, TaiwanSELECTBIOenquiries@selectbiosciences.com

We will share thousand patients’ data of ctDNA assay with cSMART technology for NSCLC. It combined the clinical treatment and molecular data. The data will point out the high sensitive and absolute quantity through cSMART technology.

Add to Calendar ▼2016-12-01 00:00:002016-12-02 00:00:00Europe/LondonNext Generation Sequencing Asia 2016: Clinical ApplicationsNext Generation Sequencing Asia 2016: Clinical Applications in Taipei, TaiwanTaipei, TaiwanSELECTBIOenquiries@selectbiosciences.com


Corporate Sponsors